Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)
NCT04740346 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 886
Last updated 2021-10-27
Summary
This study is a multi-center, prospective, randomized controlled study. The aim of this study is to compare survival rates and to observe quality of life and nutritional status according to follow-up period in patients who underwent radical gastrectomy for stage 2 or 3 gastric cancer.
Conditions
- Gastric Cancer
- Recurrence
- Quality of Life
Interventions
- DIAGNOSTIC_TEST
-
Computed tomography, Chest X-ray, and blood test
CT will be performed every 3 months after gastrectomy in the 3-months follow-up group. CT will be performed every 6 months after gastrectomy in the 6 months follow-up group.
Sponsors & Collaborators
-
Korea Health Industry Development Institute
collaborator OTHER_GOV -
National Cancer Center, Korea
lead OTHER_GOV
Principal Investigators
-
Keun Won Ryu, MD PhD · National Cancer Center, Korea
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-05
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)
NCT06608381 ·Status: RECRUITING ·Phase: PHASE3
-
POF Versus FOLFOX Plus IP Paclitaxel in AGC
NCT04155671 ·Status: UNKNOWN ·Phase: PHASE2
-
Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers
NCT03468712 ·Status: UNKNOWN ·Phase: NA
-
Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
NCT00587145 ·Status: UNKNOWN ·Phase: PHASE2
-
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer
NCT00134095 ·Status: UNKNOWN ·Phase: PHASE2
-
POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC
NCT02845908 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer
NCT02327481 ·Status: COMPLETED ·Phase: NA
-
A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer
NCT01946061 ·Status: TERMINATED ·Phase: PHASE2
-
Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer
NCT03647969 ·Status: COMPLETED ·Phase: PHASE2
-
Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
NCT06597227 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of TKcell in Advanced Gastric Cancer
NCT00854854 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Fast Track Surgery With Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer: a Randomized Controlled Trial
NCT01955096 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy
NCT02404753 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma
NCT03814759 ·Status: COMPLETED ·Phase: PHASE2
-
S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma
NCT01364376 ·Status: COMPLETED ·Phase: NA
-
Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT03874871 ·Status: UNKNOWN
-
Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
NCT03443856 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
NCT01917552 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT04843215 ·Status: RECRUITING ·Phase: NA
-
Robotic Versus Laparoscopic Radical Surgery for Locally Advanced Gastric Cancer
NCT06791538 ·Status: RECRUITING ·Phase: NA
-
QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
NCT07315035 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer
NCT00512681 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study of Laparoscopy-assisted D2 Distal Gastrectomy to Treat Advanced Gastric Cancer
NCT01088204 ·Status: UNKNOWN ·Phase: PHASE2
-
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
NCT01824004 ·Status: COMPLETED ·Phase: PHASE2
-
Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS)
NCT02745509 ·Status: COMPLETED ·Phase: NA